home / stock / a / a news


A News and Press, Agilent Technologies Inc. From 11/15/23

Stock Information

Company Name: Agilent Technologies Inc.
Stock Symbol: A
Market: NYSE
Website: agilent.com

Menu

A A Quote A Short A News A Articles A Message Board
Get A Alerts

News, Short Squeeze, Breakout and More Instantly...

A - Agilent Technologies raises quarterly dividend by 5% to $0.236/share

2023-11-15 16:29:40 ET More on Agilent Technologies Agilent Not As Agile As Hoped As Life Sciences Demand Proves To Be Less Than Invincible Agilent: Dips Into GARP Territory, Shares At A Crucial Spot On The Chart Agilent gastric cancer assay wins FDA nod ...

A - Agilent Increases Cash Dividend to 23.6 Cents per Share

Agilent Technologies Inc. (NYSE: A) today announced the company has increased its quarterly dividend to 23.6 cents per share of common stock, a 5% increase over the previous dividend. The quarterly dividend will be paid on Jan. 24, 2024, to all shareholders of record as of the close of business o...

A - Atara Biotherapeutics director purchases 100K company shares

2023-11-15 13:09:37 ET More on Atara Biotherapeutics Atara Biotherapeutics: Market Overreaction To Failed MS Study Creates Buy Opportunity Atara's Balancing Act: Innovation On A Fiscal Tightrope Atara Biotherapeutics, Inc. (ATRA) Q3 2023 Earnings Call Transcript ...

A - Agilent gastric cancer assay wins FDA nod

2023-11-14 08:52:33 ET The U.S. FDA has approved Agilent's ( NYSE: A ) PD-L1 IHC 22C3 pharmDx as a companion diagnostic for identifying patients with gastric or gastroesophageal junction (GEJ) adenocarcinoma who may be eligible for Merck's ( MRK ) Keytruda (pembrolizumab) tr...

A - Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Patients with gastric or GEJ adenocarcinoma whose tumors express PD-L1 can now be identified for potential treatment with KEYTRUDA® (pembrolizumab) using PD-L1 IHC 22C3 pharmDx (SK006) Agilent Technologies Inc. (NYSE: A) today announced that it has received FDA approval for t...

A - Nike, Merck Among 13 Companies To Announce Annual Dividend Increases In Second Half Of November

2023-11-13 10:12:35 ET Summary Investors were rewarded with 10%+ dividend increases from Snap-on Tools and ADP in the first half of November. Other companies that rewarded investors in the first two weeks of the month were Emerson, which extended its dividend growth streak to 67 y...

A - Agilent Announces Thought Leader Award to Professor Jennifer Field

Oregon State University researcher recognized for her pioneering work with organic micropollutants and PFAS Agilent Technologies Inc. (NYSE: A) today announced that Jennifer Field, an influential researcher in environmental analysis, has been selected to receive a prestigious Agilent ...

A - Exxon was most shorted S&P 500 stock last month, topping Tesla - BI

2023-11-11 20:30:00 ET More on Exxon Mobil Exxon Mobil: Don't Miss The New Traditional Energy Supercycle Exxon Mobil: Waltz Across Texas Exxon Mobil: The Advantage Of Organic Growth For further details see: Exxon was most shorted S&P 500 stock last mo...

A - U.S. Wide-Moat Stocks On Sale - The November 2023 Heat Map

2023-11-10 16:05:35 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...

A - Luokung announces receipt of Nasdaq notification regarding minimum bid price deficiency

2023-11-08 17:00:54 ET More on Luokung Technology Corp. Financial information for Luokung Technology Corp. For further details see: Luokung announces receipt of Nasdaq notification regarding minimum bid price deficiency

Previous 10 Next 10